Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06019975

FDG-PET in the Diagnosis of Autoimmune Encephalitis

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
University of Milano Bicocca · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is: •is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFDG-PETBrain FDG-PET

Timeline

Start date
2023-03-01
Primary completion
2027-03-31
Completion
2027-04-30
First posted
2023-08-31
Last updated
2026-03-24

Locations

6 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06019975. Inclusion in this directory is not an endorsement.

FDG-PET in the Diagnosis of Autoimmune Encephalitis (NCT06019975) · Clinical Trials Directory